Euromelanoma in Portugal 2010-2016
Resumo
Introdução: A incidência dos cancros da pele tem vindo a aumentar nos últimos anos em todo o mundo. O alerta das populações para a prevenção primária, promovendo o conhecimento sobre factores de risco e incentivando melhores comportamentos de proteção solar, bem como a prevenção secundária fomentando o auto-exame de pele e rastreios, são estratégias fundamentais da luta contra o cancro da pele. A Sociedade Portuguesa de Dermatologia e Venereologia e a Associação Portuguesa de Cancro Cutâneo, têm colaborado com o Euromelanoma, uma iniciativa pan-Europeia de informação e rastreio de cancro da pele, desde o ano 2000.
Material e Métodos: Este estudo transversal consistiu na avaliação dos dados do formulário do Euromelanoma preenchido aquando do rastreio no dia do Euromelanoma, em Portugal Continental e Ilhas, nas instituições públicas e privadas, de 2010 a 2016.
Resultados: Foram incluídos 9862 indivíduos, 63% mulheres e 37% homens, com uma média de idades de 48 anos. O número de lesões clinicamente suspeitas de malignidade, ou de risco de malignidade, foi relativamente baixo mas consistente com outros estudos publicados do Euromelanoma: 3% carcinoma basocelular, 0,4% carcinoma espinocelular, 1% melanoma e 6% de queratoses actínicas.
Conclusão: A iniciativa do Euromelanoma suscitou a nível nacional e internacional uma maior sensibilização das populações para a temática do cancro da pele, com amplificação das mensagens pela comunicação social, assumindo-se como um importante tema de saúde pública, reconhecido pelas autoridades políticas e sanitárias.
Downloads
Referências
US Preventive Services Task Force. Screening for skin cancer:
recommendations and rationale. Am J Prev Med.
; 20(3 Suppl):44-6.
Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli
G, Blasi PR. Screening for Skin Cancer in Adults:
Updated Evidence Report and Systematic Review for the
US Preventive Services Task Force. JAMA. 2016; 316:436-
Stratigos AJ, Forsea AM, van der Leest RJ, de Vries E, Nagore
E, Bulliard JL,et al. Euromelanoma: a dermatology-
-led European campaign against nonmelanoma skin
cancer and cutaneous melanoma. Past, present and future.
Br J Dermatol. 2012;167 Suppl 2:99-104.
Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert
R, Volkmer B, et al. Systematic skin cancer screening
in Northern Germany. J Am Acad Dermatol. 2012;
:201-11.
Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock
MA, Daniels S, et al. The first 15 years of the American
Academy of Dermatology skin cancer screening programs:
-1999. J Am Acad Dermatol. 2003; 48:34-41.
Dobbinson SJ, Wakefield MA, Jamsen KM, Herd NL, Spittal
MJ, Lipscomb JE, et al. Weekend sun protection and
sunburn in Australia trends (1987-2002) and association
with SunSmart television advertising. Am J Prev Med.
; 34:94-101.
Breitbart EW, Greinert R, Volkmer B. Effectiveness of information
campaigns. Prog Biophys Mol Biol. 2006; 92:167-
Greinert R, Boniol M. Skin cancer--primary and secondary
prevention (information campaigns and screening) - with
a focus on children & sunbeds. Prog Biophys Mol Biol.
; 107:473-6.
Amaro JA, Pecegueiro M, Quental A. Skin cancer screening
in a urban population. Skin Cancer. 1990; 5: 147-
Vandaele MM, Richert B, Van der Endt JD, Boyden B, Brochez
L, del Marmol V, et al. Melanoma screening: results
of the first one-day campaign in Belgium ('melanoma
Monday'). J Eur Acad Dermatol Venereol. 2000; 14:470-
Roche L, Foley CC, McCarthy S, Murphy M. The old reliables
outperform new media in social marketing of Euromelanoma
in Ireland: J Eur Acad Dermatol Venereol.
; 31:e296.
Correia O. A importância da prevenção primária do cancro
da pele. Acta Fotobiol. 2004; 19:19-24.
Correia O, Barros AM, Rocha N, et al. Skin cancer primary
prevention programme for school children. Analysis of
behavioral practices. Skin Cancer. 2006; 21:67-76.
Correia O, Barros AM, Quirino P, Rocha N, Ribeiro O,
Feijó A, Silva J, Pignatelli J, Pereira A. Skin cancer primary
prevention action in Portuguese beaches and analysis
of behaviour regarding sun exposure. Skin Cancer. 2007;
:7-19.
Correia O, Correia B, Duarte AF. A skin cancer prevention
campaign: spreading the word on sugar packets. JAMA
Dermatol. 2016 (in press).
Lim HW, Schneider SL. Sun safety practices-progress
made, more to go. JAMA Dermatol. 2017; 153:379-80.
Correia O, Duarte AF, Barros AM, Girão L, Picoto A. Muppies
as a way of skin cancer primary prevention. J Am
Acad Dermatol 2009: 60;AB94.
Mahon SM. Skin cancer prevention: education and public
health issues. Semin Oncol Nurs. 2003; 19:52-61.
Forsea AM, del Marmol V. Impact, challenges and perspectives
of Euromelanoma, a pan-European campaign
of skin cancer prevention: J Eur Acad Dermatol Venereol.
; 27:1317-9.
van der Leest RJ, de Vries E, Bulliard JL, Paoli J, Peris K,
Stratigos AJ, et al. The Euromelanoma skin cancer prevention
campaign in Europe: characteristics and results of
and 2010. J Eur Acad Dermatol Venereol. 2011;
:1455-65.
Stratigos A, Nikolaou V, Kedicoglou S, Antoniou C, Stefanaki
I, Haidemenos G, et al. Melanoma/skin cancer
screening in a Mediterranean country: results of the Euromelanoma
Screening Day Campaign in Greece. J Eur
Acad Dermatol Venereol. 2007; 21:56-62.
Koh HK, Geller AC, Miller DR, Caruso A, Gage I, Lew RA.
Who is being screened for melanoma/skin cancer? Characteristics
of persons screened in Massachusetts. J Am
Acad Dermatol. 1991; 24(2 Pt 1):271-7.
Suppa M, Altomare G, Cannavo SP, Capizzi R, Catricalà
C, Colombo E, et al. The Italian Euromelanoma Day: evaluation
of results and implications for future prevention
campaigns. Int J Dermatol. 2014;53:699-706.
Bulliard JL, Maspoli M, Panizzon RG, Hohl D, Gueissaz F,
Levi F. Evaluation of the Euromelanoma skin cancer screening
campaign: the Swiss experience. J Eur Acad Dermatol
Venereol. 2008; 22:365-66.
de Vries E, Coebergh JW. Melanoma incidence has risen
in Europe: BMJ. 2005; 331:698.
Del Marmol V, de Vries E, Roseeuw D, Pirard C, van der
Endt J, Trakatelli M, et al. A Prime minister managed to attract
elderly men in a Belgian Euromelanoma campaign.
Eur J Cancer. 2009; 45:1532-4.
Suppa M, Neri L, Bianchi L, Capizzi R, Carbone A, Catricalà
C, et al. The first skin cancer screening day at the
Italian parliament: a Euromelanoma initiative. Int J Dermatol.
; 54:42-9.
Paoli J, Danielsson M, Wennberg AM. Results of the 'Euromelanoma
Day' screening campaign in Sweden 2008. J
Eur Acad Dermatol Venereol. 2009; 23:1304-10.
Seidenari S, Benati E, Ponti G, Borsari S, Ferrari C, Albertini
G et al. Italian Euromelanoma Day Screening Campaign
(2005-2007) and the planning of melanoma screening
strategies. Eur J Cancer Prev. 2012; 21:89-95.
Diehl K, Litaker DG, Greinert R, Zimmermann S, Breitbart
EW, Schneider S. The prevalence of current sunbed use
and user characteristics: the SUN-Study 2008. Int J Public
Health. 2010; 55:513-6.
Duarte AF, Maia Silva JN, Costa Pereira A, Nagore E, Picoto
A, Correia O. Sunbed use among Portuguese beach
goers: a crave group while waiting sunbeds to be abolished.
J Eur Acad Dermatol Venereol. 2017; 31:e294-
-e295.
Autier P, Boniol M, Dore JF. Sunscreen use and increased
duration of intentional sun exposure: still a burning issue.
Int J Cancer. 2007; 121:1-5.
Thieden E, Philipsen PA, Sandby-Moller J, Wulf HC. Sunscreen
use related to UV exposure, age, sex, and occupation
based on personal dosimeter readings and sun-exposure
behavior diaries. Arch Dermatol. 2005; 141:967-73.
Gefeller O, Pfahlberg A. Sunscreen use and melanoma: a
case of evidence-based prevention? Photodermatol Photoimmunol
Photomed. 2002; 18:153-6.
Aviles-Izquierdo JA, Molina-Lopez I, Rodriguez-Lomba E,
Marquez-Rodas I, Suarez-Fernandez R, Lazaro-Ochaita P.
Who detects melanoma? Impact of detection patterns on
characteristics and prognosis of patients with melanoma.
J Am Acad Dermatol. 2016; 75:967-74.
Aitken JF, Elwood M, Baade PD, Youl P, English D. Clinical
whole-body skin examination reduces the incidence of
thick melanomas. Int J Cancer. 2010; 126:450-8.
Walton AE, Janda M, Youl PH, Baade P, Aitken JF, Whiteman
DC, et al. Uptake of skin self-examination and
clinical examination behavior by outdoor workers. Arch
Environ Occup Health. 2014; 69:214-22.
Duarte AF, Correia B, Picoto A, Costa Pereira A, Nagore E,
Correia O. Behaviour towards sun exposure, skin self-examination
and skin cancer knowledge of educators, health
professionals and the general population - cross-sectional
study: J Eur Acad Dermatol Venereol. 2017; 31:e132-
-e135.
Moreno Gimenez JC. The Euromelanoma Campaign:
Actas Dermosifiliogr. 2017; 108:389-91.
Duarte AF, da Costa-Pereira A, Del-Marmol V, Correia
O. Are General Physicians Prepared for Struggling Skin
Cancer?-Cross-Sectional Study. J Cancer Educ. 2016;
:13.
Badertscher N, Braun RP, Held U, Kofmehl R, Senn O, Hofbauer
GF, et al. Diagnostic competence of Swiss general
practitioners in skin cancer. Swiss Medical Wkly. 2013;
:13834.
Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken
J, Boniol M, et al. A nationwide population-based skin
cancer screening in Germany: proceedings of the first
meeting of the International Task Force on Skin Cancer
Screening and Prevention (September 24 and 25, 2009).
Cancer Epidemiol. 2010; 34:355-8.
Boniol M, Autier P, Gandini S. Melanoma mortality
following skin cancer screening in Germany. BMJ Open.
; 5:2015-008158.
Kaiser M, Schiller J, Schreckenberger C. The effectiveness
of a population-based skin cancer screening program:
evidence from Germany. Eur J Health Econ. 2017;
:017-0888.
Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact
of skin cancer screening and secondary prevention
campaigns on skin cancer incidence and mortality: A
systematic review. J Am Acad Dermatol. 2017; 76:129-
Grange F, Woronoff AS, Bera R, Colomb M, Lavole B,
Fournier E, et al. Efficacy of a general practitioner training
campaign for early detection of melanoma in France. Br J
Dermatol. 2014; 170:123-9.
Conejo-Mir J, Bravo J, Diaz-Perez JL, Fernández-Herrera J,
Guillén C, Martí R, et al. Dia del Euromelanoma. Resultados
en Espana de las campanas de 2000, 2001 y 2002.
Actas Dermo-Sifiliogr. 2005; 96:217-21.
Todos os artigos desta revista são de acesso aberto sob a licença internacional Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0).
